New treatment Xadago to help 100,000 Canadians living with Parkinson’s

News

Author: Parkinson's Life editorsPublished: 5 May 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

More than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.

The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.

Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.

Go Back

Share this story

Comments


Related articles


Kim Petrie with The Trews

Interviews

Kim Petrie: “How I raised $250,000 for Parkinson’s research”

Kim Petrie tells us how she raised $250,000 to fight Parkinson’s

READ MORE

Interviews

How these laser-guided shoes keep Parkinson’s patients on their feet

Meet the inventor of a laser-guided shoe for Parkinson’s patients

READ MORE
Brian Lowe at the World Parkinson Congress in Japan

Global update

‘Chopsticks are not easy for a person with Parkinson’s’

In the third in our series on this year’s World Parkinson Congress (WPC),

READ MORE